Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 13 Similar Profiles
Therapeutics Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Radiation Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2017

Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis

Kim, B. H., Kwon, J., Chie, E. K., Kim, K., Kim, Y. H., Seo, D. W., Narang, A. K. & Herman, J. M. Oct 27 2017 (Accepted/In press) In : Annals of Surgical Oncology. p. 1-10 10 p.

Research output: Research - peer-reviewArticle

Adjuvant Chemoradiotherapy
Adjuvant Radiotherapy

A Novel Absorbable Radiopaque Hydrogel Spacer to Separate the Head of the Pancreas and Duodenum in Radiation Therapy for Pancreatic Cancer

Rao, A. D. , Feng, Z. , Shin, E. J. , He, J. , Waters, K. M. , Coquia, S. , DeJong, R. , Rosati, L. M. , Su, L. , Li, D. , Jackson, J. , Clark, S. , Schultz, J. , Hutchings, D. , Kim, S. H. , Hruban, R. H. , DeWeese, T. L. , Wong, J. , Narang, A. , Herman, J. M. & 1 others Ding, K. 2017 (Accepted/In press) In : International Journal of Radiation Oncology Biology Physics.

Research output: Research - peer-reviewArticle

Pancreatic Neoplasms

End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer

Narang, A. K., Trieu, J., Radwan, N., Ram, A., Robertson, S. P., He, P., Gergis, C., Griffith, E., Singh, H., DeWeese, T. A., Honig, S., Annadanam, A., Greco, S., DeVille, C., McNutt, T., DeWeese, T. L., Song, D. Y. & Tran, P. T. Jan 17 2017 (Accepted/In press) In : Prostate Cancer and Prostatic Diseases.

Research output: Research - peer-reviewArticle

Prostatic Neoplasms

Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer

Shrestha, B. , Sun, Y. , Faisal, F. , Kim, V. , Soares, K. , Blair, A. , Herman, J. M. , Narang, A. , Dholakia, A. S. , Rosati, L. , Hacker-Prietz, A. , Chen, L. , Laheru, D. A. , De Jesus-Acosta, A. , Le, D. T. , Donehower, R. , Azad, N. , Diaz, L. A. , Murphy, A. , Lee, V. & 11 others Fishman, E. K., Hruban, R. H., Liang, T., Cameron, J. L., Makary, M., Weiss, M. J., Ahuja, N., He, J., Wolfgang, C. L., Huang, C. Y. & Zheng, L. Jul 1 2017 In : Cancer Medicine. 6, 7, p. 1552-1562 11 p.

Research output: Research - peer-reviewArticle

Pancreatic Neoplasms
Drug Therapy
Neoadjuvant Therapy

Out-of-pocket spending and financial burden among medicare beneficiaries with cancer

Narang, A. K. & Nicholas, L. H. Jun 1 2017 In : JAMA Oncology. 3, 6, p. 757-765 9 p.

Research output: Research - peer-reviewArticle

Health Expenditures